The inhibition of cancer cell stickness by the methylxanthine derivative pentoxifylline (BL 191).
D000818:Animals; D001772:Blood Cell Count; D001777:Blood Coagulation; D001792:Blood Platelets / Q000187:drug effects / Q000201:enzymology; D002279:Carcinoma 256, Walker / Q000473:pathology*; D002448:Cell Adhesion / Q000187:drug effects*; D002462:Cell Membrane; D004305:Dose-Response Relationship, Drug; D004727:Endothelium; D005342:Fibrinolysis; D008643:Mesentery; D009362:Neoplasm Metastasis; D009368:Neoplasm Transplantation; D009360:Neoplastic Cells, Circulating; D010726:Phosphodiesterase Inhibitors; D010973:Platelet Adhesiveness / Q000187:drug effects; D010974:Platelet Aggregation / Q000187:drug effects; D051381:Rats; D014184:Transplantation, Homologous; D014970:Xanthines / Q000008:administration & dosage / Q000494:pharmacology*
D010726:Phosphodiesterase Inhibitors; D014970:Xanthines